Press releases

2025

2025-04-29 13:50 Kallelse till årsstämma i Intellego Technologies AB (publ) News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
Aktieägarna i Intellego Technologies AB (publ), org. nr 556864-1624, kallas härmed till årsstämma onsdagen den 4 juni 2025 kl. 14.00...
2025-04-04 10:00 Intellego surpasses 160 million SEK in EBIT for 2025 News Corporate Information Other Corporate Information English Regulatory MAR IR
Intellego Technologies AB (publ) announces that the Company has already achieved an EBIT result of 160 million SEK for 2025. This goal, announced earlier...
2025-04-01 10:00 Intellego announces preliminary Q1 2025 financial results News Corporate Information Other Corporate Information English Regulatory MAR IR
Intellego Technologies (publ) reports preliminary results for the first quarter of 2025. · Revenue exceeds 200 million SEK, an increase of approximately...
Due to a positive reception on the dosimeter products, Intellego and Likang have agreed speed up the deliveries for the Chinese market but also to expand...
2025-02-28 18:00 Intellego Technologies Interim Report Q4 2024 News English Regulatory MAR Report Interim Yearend IR
Summary of the period 1 October to 31 December 2024 Summary of the period 1 January to 31 December 2024 The entire quarterly report is available at: https://intellego-technologies.com/sv/rapporter/...
2025-02-26 14:00 Intellego and Henkel announce global collaboration for the PSA market News Corporate Information Other Corporate Information English IR
Intellego and Henkel have been working together for several years on a project within the global UV curing PSA market (Pressure Sensitive Adhesives). The...
2025-01-14 08:45 Intellego enters into collaboration with a US company for the sterilization industry, to a minimum value of approximately USD 60 million over 5 years News Corporate Information Other Corporate Information English Regulatory MAR IR
Intellego has entered into a collaboration with a US company active in the healthcare sterilization industry. The US company has been using Intellego’s...
2025-01-10 18:00 Intellego announces preliminary 2024 numbers and updates on 2025 progress News Corporate Information Other Corporate Information English Regulatory MAR IR
Intellego’s annual net revenue for 2024 is expected to reach approximately SEK 267 million, which is approximately 11 percent lower than originally...

2024

2024-12-30 15:00 Intellego announces a record-high order book of approximately MSEK 300 for 2025 News Corporate Information Other Corporate Information English IR
Intellego Technologies AB (publ) (“Intellego” or the “Company”) is pleased to announce a record-high order book of approximately...
2024-12-13 08:45 Intellego’s Managing Director, Asia Pacific David Chen exercises warrants and Intellego receives approximately SEK 2.2 million News Corporate Action Other English Regulatory Listing Regulation IR
Intellego Technologies AB (publ) (“Intellego” or the “Company”) today announces the outcome of the exercise of warrants of series...

2024

2024-11-29 08:49 Correction: Intellego Quarterly Report 1 July to 30 September 2024 News Correction English Regulatory Listing Regulation Report Interim Q3 IR
In the quarterly report distributed on November 28, 2024, there was an error in the attached PDF report. The item "Change of stock" on page 16...
2024-11-28 18:00 Intellego Quarterly Report 1 July to 30 September 2024 News English Regulatory MAR Report Interim Q3 IR
Summary of the period 1 July to 30 September 2024 The entire quarterly report is available at: https://intellego-technologies.com/sv/rapporter/ A Message...
2024-11-28 14:41 Correction: Intellego Technologies AB appoints Mangold Fondkommission as new Certified Adviser News Corporate Information Other Corporate Information Correction English Regulatory Listing Regulation IR
The message incorrectly stated that Carnegie Investment Bank AB (publ) was still listed as the Certified Adviser in the sender text (Boiler Plate). The...
2024-11-28 13:48 Intellego Technologies AB appoints Mangold Fondkommission as new Certified Adviser News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Intellego Technologies AB has entered into an agreement with Mangold Fondkommission AB (“Mangold”) regarding the service as Certified Adviser...
2024-11-18 15:00 Intellego and Likang expand collaboration with USD 360M, five-year deal in Asia News Corporate Information Other Corporate Information English Regulatory MAR IR
Due to a positive reception of the dosimeter products, Intellego and Likang have agreed to expand their collaboration to cover additional products in the...
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG...
2024-10-25 14:06 Intellego’s former Board members exercises warrants and Intellego receives approximately SEK 5.0 million News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Intellego Technologies AB (publ) (“Intellego” or the “Company”) today announces the outcome of the exercise of warrants of series...
2024-09-19 19:50 Intellego Technologies carries out a directed issue of units of approximately SEK 15.2 million News Corporate Action Shares Issuance English Regulatory MAR IR
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG...
2024-08-30 18:00 Intellego Quarterly Report 1 April to 30 June 2024 News English Regulatory MAR Report Interim Q2 IR
Summary of the period 1 April to 30 June 2024 The entire quarterly report is available at: https://intellego-technologies.com/sv/rapporter/ A message from...
2024-08-23 18:00 Intellego Postpones Q2 Report to August 30th News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Intellego has decided to postpone the publication of its Q2 report to the 30th of August. The reason for the postponement is the recent conclusion of the...